| Massachusetts General Hospital, the Infectious Disease Diagnostics Laboratory at Children’s Hospital of Philadelphia, and the Diagnostic Molecular Laboratory at Northwestern Medicine, have received federal approval to produce tests to detect COVID-19. All three organization’s real-time tests were cleared by the U.S. Food and Drug Administration last week for detecting COVID-19 using nasopharyngeal swabs, nasal swabs, and bronchoalveolar lavage specimens. The slow roll-out of testing for the coronavirus has prompted more hospitals to develop their own diagnostic capabilities, which they say offers them the best chance to mitigate the impact of the outbreak. It also has given them better control over who to test and expedites the results. However, the Trump administration sent a letter to hospitals requesting that they report their COVID-19 testing data to HHS on a daily basis. Test results are due to HHS every day at 5 p.m. ET. |
Connect - Convene - Collaborate